{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:16:12Z","timestamp":1792181772519,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cell models of mitochondrial complex I (CI) deficiency display activation of glycolysis to compensate for the loss in mitochondrial ATP production. This adaptation can mask other relevant deficiency-induced aberrations in cell physiology. Here we investigated the viability, mitochondrial morphofunction, ROS levels and ATP homeostasis of primary skin fibroblasts from Leigh Syndrome (LS) patients with isolated CI deficiency. These cell lines harbored mutations in nuclear DNA (nDNA)-encoded CI genes (<jats:italic>NDUFS7<\/jats:italic>, <jats:italic>NDUFS8<\/jats:italic>, <jats:italic>NDUFV1<\/jats:italic>) and, to prevent glycolysis upregulation, were cultured in a pyruvate-free medium in which glucose was replaced by galactose. Following optimization of the cell culture protocol, LS fibroblasts died in the galactose medium, whereas control cells did not. LS cell death was dose-dependently inhibited by pyruvate, malate, oxaloacetate, \u03b1-ketoglutarate, aspartate, and exogenous NAD<jats:sup>+<\/jats:sup> (eNAD), but not by lactate, succinate, \u03b1-ketobutyrate, and uridine. Pyruvate and eNAD increased the cellular NAD<jats:sup>+<\/jats:sup> content in galactose-treated LS cells to a different extent and co-incubation studies revealed that pyruvate-induced rescue was not primarily mediated by NAD<jats:sup>+<\/jats:sup>. Functionally, in LS cells glucose-by-galactose replacement increased mitochondrial fragmentation and mass, depolarized the mitochondrial membrane potential (\u0394\u03c8), increased H<jats:sub>2<\/jats:sub>DCFDA-oxidizing ROS levels, increased mitochondrial ATP generation, and reduced the total cellular ATP content. These aberrations were differentially rescued by pyruvate and eNAD, supporting the conclusion that these compounds rescue galactose-induced LS cell death via different mechanisms. These findings establish a cell-based strategy for intervention testing and enhance our understanding of CI deficiency pathophysiology.<\/jats:p>","DOI":"10.1038\/s41419-018-1179-4","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T12:28:35Z","timestamp":1542198515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Rescue from galactose-induced death of Leigh Syndrome patient cells by pyruvate and NAD+"],"prefix":"10.1038","volume":"9","author":[{"given":"Eligio F.","family":"Iannetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A. M.","family":"Smeitink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H. G. M.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Beyrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-6747","authenticated-orcid":false,"given":"Werner J. H.","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"1179_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35072063","volume":"2","author":"J Smeitink","year":"2001","unstructured":"Smeitink, J., Van Den Heuvel, L. & DiMauro, S. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2, 342\u2013352 (2001).","journal-title":"Nat. Rev. Genet."},{"key":"1179_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nrneurol.2013.129","volume":"9","author":"G Pfeffer","year":"2013","unstructured":"Pfeffer, G. et al. New treatments for mitochondrial disease-no time to drop our standards. Nat. Rev. Neurol. 9, 474\u2013481 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"1179_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.15252\/emmm.201506131","volume":"8","author":"WJH Koopman","year":"2016","unstructured":"Koopman, W. J. H. et al. Mitochondrial disorders in children: toward development of small-molecule treatment strategies. EMBO Mol. Med. 8, 311\u2013327 (2016).","journal-title":"EMBO Mol. Med."},{"key":"1179_CR4","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/brain\/aww081","volume":"139","author":"H Nightingale","year":"2016","unstructured":"Nightingale, H., Pfeffer, G., Bargiela, D., Horvath, R. & Chinnery, P. F. Emerging therapies for mitochondrial disorders. Brain 139, 1633\u20131648 (2016).","journal-title":"Brain"},{"key":"1179_CR5","doi-asserted-by":"publisher","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","volume":"2","author":"Gr\u00e1inne S. Gorman","year":"2016","unstructured":"Gorman, G. S. et al. Mitochondrial diseases. Nat. Rev. Dis. Prim. 2, 16080 (2016).","journal-title":"Nature Reviews Disease Primers"},{"key":"1179_CR6","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.bbabio.2016.02.012","volume":"1857","author":"RJ Rodenburg","year":"2016","unstructured":"Rodenburg, R. J. Mitochondrial complex I-linked disease. Biochim. Biophys. Acta - Bioenerg. 1857, 938\u2013945 (2016).","journal-title":"Biochim. Biophys. Acta - Bioenerg."},{"key":"1179_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/15216540152845920","volume":"52","author":"AD Vinogradov","year":"2001","unstructured":"Vinogradov, A. D. & Grivennikova, V. G. The mitochondrial complex I: progress in understanding of catalytic properties. IUBMB Life 52, 129\u2013134 (2001).","journal-title":"IUBMB Life"},{"key":"1179_CR8","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1074\/jbc.M113.498626","volume":"289","author":"CE Christensen","year":"2014","unstructured":"Christensen, C. E., Karlsson, M., Winther, J. R., Jensen, P. R. & Lerche, M. H. Non-invasive in-cell determination of free cytosolic [NAD+]\/[NADH] ratios using hyperpolarized glucose show large variations in metabolic phenotypes. J. Biol. Chem. 289, 2344\u20132352 (2014).","journal-title":"J. Biol. Chem."},{"key":"1179_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1126\/science.aad4017","volume":"352","author":"DV Titov","year":"2016","unstructured":"Titov, D. V. et al. Complementation of mitochondrial electron transport chain by manipulation of the NAD+\/NADH ratio. Science 352, 231\u2013235 (2016).","journal-title":"Science"},{"issue":"20","key":"1179_CR10","doi-asserted-by":"publisher","first-page":"7490","DOI":"10.1074\/jbc.TM117.000239","volume":"293","author":"Aaron M. Hosios","year":"2018","unstructured":"Hosios, A. M. & Vander Heiden, M. G. The redox requirements of proliferating mammalian cells. J. Biol. Chem. 293, 7490\u20137498 (2018).","journal-title":"Journal of Biological Chemistry"},{"key":"1179_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ceca.2008.01.002","volume":"44","author":"PHGM Willems","year":"2008","unstructured":"Willems, P. H. G. M. et al. Mitochondrial Ca2+homeostasis in human NADH: ubiquinone oxidoreductase deficiency. Cell Calcium 44, 123\u2013133 (2008).","journal-title":"Cell Calcium"},{"key":"1179_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00109-009-0452-5","volume":"87","author":"F Distelmaier","year":"2009","unstructured":"Distelmaier, F. et al. The antioxidant Trolox restores mitochondrial membrane potential and Ca2+-stimulated ATP production in human complex I deficiency. J. Mol. Med. 87, 515\u2013522 (2009).","journal-title":"J. Mol. Med."},{"key":"1179_CR13","doi-asserted-by":"publisher","first-page":"C22","DOI":"10.1152\/ajpcell.00194.2006","volume":"293","author":"WJH Koopman","year":"2007","unstructured":"Koopman, W. J. H. et al. Human NADH: ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology? Am. J. Physiol. Cell Physiol. 293, C22\u2013C29 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1179_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bbadis.2007.05.004","volume":"1772","author":"S Verkaart","year":"2007","unstructured":"Verkaart, S. et al. Mitochondrial and cytosolic thiol redox state are not detectably altered in isolated human NADH:ubiquinone oxidoreductase deficiency. Biochim. Biophys. Acta 1772, 1041\u20131051 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"1179_CR15","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.bbabio.2012.03.006","volume":"1817","author":"F Valsecchi","year":"2012","unstructured":"Valsecchi, F. et al. Metabolic consequences of NDUFS4 gene deletion in immortalized mouse embryonic fibroblasts. Biochim. Biophys. Acta 1817, 1925\u20131936 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"1179_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cmet.2013.07.002","volume":"18","author":"G Karamanlidis","year":"2013","unstructured":"Karamanlidis, G. et al. Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell. Metab. 18, 239\u2013250 (2013).","journal-title":"Cell. Metab."},{"key":"1179_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.biochem.75.103004.142539","volume":"75","author":"U Brandt","year":"2006","unstructured":"Brandt, U. Energy converting NADH:quinone oxidoreductase (complex I). Annu. Rev. Biochem. 75, 69\u201392 (2006).","journal-title":"Annu. Rev. Biochem."},{"key":"1179_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0076-6879(96)64041-5","volume":"264","author":"BH Robinson","year":"1996","unstructured":"Robinson, B. H. Use of fibroblast and lymphoblast cultures for detection of respiratory chain defects. Methods Enzymol. 264, 454\u2013464 (1996).","journal-title":"Methods Enzymol."},{"key":"1179_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1172\/JCI118798","volume":"98","author":"S Pitkanen","year":"1996","unstructured":"Pitkanen, S. & Robinson, B. H. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J. Clin. Invest. 98, 345\u2013351 (1996).","journal-title":"J. Clin. Invest."},{"key":"1179_CR20","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.bbabio.2014.04.008","volume":"1837","author":"M Forkink","year":"2014","unstructured":"Forkink, M. et al. Mitochondrial hyperpolarization during chronic complex I inhibition is sustained by low activity of complex II, III, IV and v. Biochim. Biophys. Acta 1837, 1247\u20131256 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"1179_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bbadis.2014.12.012","volume":"1852","author":"F Distelmaier","year":"2015","unstructured":"Distelmaier, F. et al. Mitochondrial dysfunction in primary human fibroblasts triggers an adaptive cell survival program that requires AMPK-\u03b1. Biochim. Biophys. Acta 1852, 529\u2013540 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"1179_CR22","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.bpj.2015.08.002","volume":"109","author":"DC Liemburg-Apers","year":"2015","unstructured":"Liemburg-Apers, D. C., Schirris, T. J. J., Russel, F. G. M., Willems, P. H. G. M. & Koopman, W. J. H. Mitoenergetic dysfunction triggers a rapid compensatory increase in steady-state glucose flux. Biophys. J. 109, 1372\u20131386 (2015).","journal-title":"Biophys. J."},{"key":"1179_CR23","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1242\/jcs.194480","volume":"129","author":"DC Liemburg-Apers","year":"2016","unstructured":"Liemburg-Apers, D. C., Wagenaars, J. A. L., Smeitink, J. A. M., Willems, P. H. G. M. & Koopman, W. J. H. Acute stimulation of glucose influx upon mitoenergetic dysfunction requires LKB1, AMPK, Sirt2 and mTOR\u2013RAPTOR. J. Cell. Sci. 129, 4411\u20134423 (2016).","journal-title":"J. Cell. Sci."},{"key":"1179_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40170-015-0138-0","volume":"3","author":"L Sch\u00f6ckel","year":"2015","unstructured":"Sch\u00f6ckel, L. et al. Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth. Cancer Metab. 3, 11 (2015).","journal-title":"Cancer Metab."},{"issue":"3","key":"1179_CR25","doi-asserted-by":"publisher","first-page":"e2716","DOI":"10.1038\/cddis.2017.133","volume":"8","author":"Farhan Basit","year":"2017","unstructured":"Basit, F. et al. Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells. Cell Death Dis. 8, e2716 (2017).","journal-title":"Cell Death & Disease"},{"key":"1179_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0885-4505(92)90056-5","volume":"48","author":"BHH Robinson","year":"1992","unstructured":"Robinson, B. H. H., Petrova-Benedict, R., Buncic, J. R. R. & Wallace, D. C. C. Nonviability of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts. Biochem. Med. Metab. Biol. 48, 122\u2013126 (1992).","journal-title":"Biochem. Med. Metab. Biol."},{"key":"1179_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1096\/fasebj.10.4.8647345","volume":"10","author":"PA Frey","year":"1996","unstructured":"Frey, P. A. The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J. 10, 461\u2013470 (1996).","journal-title":"FASEB J."},{"key":"1179_CR28","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/nprot.2016.094","volume":"11","author":"EF Iannetti","year":"2016","unstructured":"Iannetti, E. F., Smeitink, J. A. M., Beyrath, J., Willems, P. H. G. M. & Koopman, W. J. H. Multiplexed high-content analysis of mitochondrial morphofunction using live-cell microscopy. Nat. Protoc. 11, 1693 (2016).","journal-title":"Nat. Protoc."},{"key":"1179_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cyto.a.20198","volume":"69A","author":"WJH Koopman","year":"2005","unstructured":"Koopman, W. J. H., Visch, H.-J., Smeitink, J. A. M. & Willems, P. H. G. M. Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts. Cytom. Part A 69A, 1\u201312 (2005).","journal-title":"Cytom. Part A"},{"key":"1179_CR30","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.bbabio.2010.01.022","volume":"1797","author":"M Forkink","year":"2010","unstructured":"Forkink, M., Smeitink, J. A. M., Brock, R., Willems, P. H. G. M. & Koopman, W. J. H. Detection and manipulation of mitochondrial reactive oxygen species in mammalian cells. Biochim. Biophys. Acta - Bioenerg. 1797, 1034\u20131044 (2010).","journal-title":"Biochim. Biophys. Acta - Bioenerg."},{"key":"1179_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-2257-4_15","volume":"1264","author":"M Forkink","year":"2015","unstructured":"Forkink, M., Willems, P. H. G. M., Koopman, W. J. H. & Grefte, S. Live-cell assessment of mitochondrial reactive oxygen species using dihydroethidine. Methods Mol. Biol. 1264, 161\u2013169 (2015).","journal-title":"Methods Mol. Biol."},{"key":"1179_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymeth.2016.06.008","volume":"109","author":"M Oparka","year":"2016","unstructured":"Oparka, M. et al. Quantifying ROS levels using CM-H2-DFCDA and HyPer. Methods 109, 3\u201311 (2016).","journal-title":"Methods"},{"key":"1179_CR33","doi-asserted-by":"crossref","unstructured":"Pittelli, M. et al. Pharmacological effects of exogenous nad on mitochondrial bioenergetics, dna repair, and apoptosis. Mol. Pharmacol. (2011).","DOI":"10.1124\/mol.111.073916"},{"key":"1179_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1096\/fj.00-0566fje","volume":"15","author":"S Bruzzone","year":"2000","unstructured":"Bruzzone, S., Guida, L., Zocchi, E., Franco, L. & De Flora, A. Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+fluxes in intact cells. FASEB J. 15, 10\u201312 (2000).","journal-title":"FASEB J."},{"key":"1179_CR35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1084\/jem.165.2.500","volume":"165","author":"J O\u2019Donnell-Tormey","year":"1987","unstructured":"O\u2019Donnell-Tormey, J., Nathan, C. F., Lanks, K., DeBoer, C. J. & de la Harpe, J. Secretion of pyruvate. An antioxidant defense of mammalian cells. J. Exp. Med. 165, 500\u2013514 (1987).","journal-title":"J. Exp. Med."},{"key":"1179_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.11.032","volume":"1132","author":"X Wang","year":"2007","unstructured":"Wang, X. et al. Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells. Brain Res. 1132, 1\u20139 (2007).","journal-title":"Brain Res."},{"key":"1179_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antiox6010021","volume":"6","author":"K Sawa","year":"2017","unstructured":"Sawa, K. et al. Krebs cycle intermediates protective against oxidative stress by modulating the level of reactive oxygen species in neuronal HT22 cells. Antioxidants 6, 21 (2017).","journal-title":"Antioxidants"},{"key":"1179_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11010-017-2942-z","volume":"429","author":"P Ramos-Ibeas","year":"2017","unstructured":"Ramos-Ibeas, P., Barandalla, M., Colleoni, S. & Lazzari, G. Pyruvate antioxidant roles in human fibroblasts and embryonic stem cells. Mol. Cell. Biochem. 429, 137\u2013150 (2017).","journal-title":"Mol. Cell. Biochem."},{"key":"1179_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/brain\/awp058","volume":"132","author":"F Distelmaier","year":"2009","unstructured":"Distelmaier, F. et al. Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain 132, 833\u2013842 (2009).","journal-title":"Brain"},{"key":"1179_CR40","doi-asserted-by":"publisher","first-page":"F758","DOI":"10.1152\/ajprenal.2000.278.5.F758","volume":"278","author":"E Bergin","year":"2000","unstructured":"Bergin, E., Levine, J. S., Koh, J. S. & Lieberthal, W. Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism. Am. J. Physiol. Ren. Physiol. 278, F758\u2013F768 (2000).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1179_CR41","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/cdd.2013.83","volume":"20","author":"N Reuven","year":"2013","unstructured":"Reuven, N., Adler, J., Meltser, V. & Shaul, Y. The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl. Cell Death Differ. 20, 1330\u20131340 (2013).","journal-title":"Cell Death Differ."},{"key":"1179_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/154065803322163777","volume":"1","author":"Y Yang","year":"2003","unstructured":"Yang, Y. & Balcarcel, R. R. 24-well plate spectrophotometric assay for preliminary screening of metabolic activity. Assay. Drug Dev. Technol. 1, 461\u2013468 (2003).","journal-title":"Assay. Drug Dev. Technol."},{"key":"1179_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt, S. Y. & Vander Heiden, M. G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell. Dev. Biol. 27, 441\u2013464 (2011).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"1179_CR44","doi-asserted-by":"crossref","unstructured":"Reitzer, J. & Wice, M. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J. Biol. Chem. 254, 2669\u20132676 (1979).","DOI":"10.1016\/S0021-9258(17)30124-2"},{"key":"1179_CR45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molcel.2014.01.011","volume":"53","author":"Y Yang","year":"2014","unstructured":"Yang, Y. et al. Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation. Mol. Cell 53, 484\u2013497 (2014).","journal-title":"Mol. Cell"},{"key":"1179_CR46","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.molcel.2018.01.034","volume":"69","author":"E Gaude","year":"2018","unstructured":"Gaude, E. et al. NADH shuttling couples cytosolic reductive carboxylation of glutamine with glycolysis in cells with mitochondrial dysfunction. Mol. Cell 69, 648\u2013663.e7 (2018).","journal-title":"Mol. Cell"},{"key":"1179_CR47","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1126\/science.2814477","volume":"246","author":"MP King","year":"1989","unstructured":"King, M. P. & Attardi, G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246, 500\u2013503 (1989).","journal-title":"Science"},{"issue":"1-2","key":"1179_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11010-017-2942-z","volume":"429","author":"Priscila Ramos-Ibeas","year":"2017","unstructured":"Ramos-Ibeas, P., Barandalla, M., Colleoni, S. & Lazzari, G. Pyruvate antioxidant roles in human fibroblasts and embryonic stem cells. Mol. Cell. Biochem. 429, 137\u2013150 (2017).","journal-title":"Molecular and Cellular Biochemistry"},{"key":"1179_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","volume":"19","author":"L Yang","year":"2017","unstructured":"Yang, L., Venneti, S. & Nagrath, D. Glutaminolysis: a hallmark of cancer metabolism.Annu. Rev. Biomed. Eng. 19, 163\u2013194 2017).","journal-title":"Annu. Rev. Biomed. Eng."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1179-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T15:01:40Z","timestamp":1672671700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1179-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1179-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"assertion":[{"value":"25 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.F.I. is a full-time employee of the SME Khondrion (). J.A.M.S. is the founding CEO of Khondrion. J.B. is the COO of Khondrion. P.H.G.M. and W.J.H.K. are scientific advisors of Khondrion. WJHK also is a scientific advisor of Mitoconix Bio. Ltd. (Ness Ziona, Israel) and of Fortify Therapeutics (Palo Alto, USA).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1135"}}